Showing results (1161-1170 of 1,343) with videos related to

Sort By:
Pageof 135
The Spine Journal : Official Journal of the North American Spine Society|October 27, 2019
Can a machine learning model accurately predict patient resource utilization following lumbar spinal fusion?Jaret M Karnuta, Joshua L Golubovsky, Heather S Haeberle, et al.
Nanoimpact|May 13, 2022
Low dose antibiotic ingestion potentiates systemic and microbiome changes induced by silver nanoparticlesMatthew J Meier, K C Nguyen, J Crosthwait, et al.
The American Journal of Sports Medicine|August 3, 2018
Interobserver and Intraobserver Reliability of an MRI-Based Classification System for Injuries to the Ulnar Collateral LigamentPrem N Ramkumar, Salvatore J Frangiamore, Sergio M Navarro, et al.
Journal of Thrombosis and Haemostasis : JTH|October 5, 2023
Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleedingTyler Quinn, Jill M Cholette, Matthew G Pinto, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 14, 2025
Neurologic features in hospitalized patients with COVID-19: a prospective cohort in a catalan hospitalOriol Barrachina-Esteve, A Anguita, A Reverter, et al.
The American Journal of Gastroenterology|August 10, 2005
A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug useAngel Lanas, Maria Angeles Perez-Aisa, Faust Feu, et al.
Revista Espanola De Enfermedades Digestivas|January 23, 2009
[Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry]M García-Cortés, Y Borraz, M I Lucena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2008
Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors StudyE Aranda, M Valladares, M Martinez-Villacampa, et al.
British Journal of Cancer|July 15, 2010
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapyE Martinez-Balibrea, A Abad, A Martínez-Cardús, et al.
Allergy|June 30, 2010
Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitisA Valero, M Ferrer, E Baró, et al.
Pageof 135